Mueller, S;
Preische, O;
Goepfert, JC;
Yanez, VAC;
Joos, TO;
Boecker, H;
Duezel, E;
... Laske, C; + view all
(2017)
Tau plasma levels in subjective cognitive decline: Results from the DELCODE study.
Scientific Reports
, 7
, Article 952. 10.1038/s41598-017-08779-0.
Preview |
Text
Tau plasma levels in subjective cognitive decline: Results from the DELCODE study.pdf - Published Version Download (920kB) | Preview |
Abstract
Previous studies have demonstrated increased tau plasma levels in patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI) due to AD. Much less is known whether increased tau plasma levels can already be detected in the pre-MCI stage of subjective cognitive decline (SCD). In the present study we measured tau plasma levels in 111 SCD patients and 134 age- and gender-matched cognitively healthy controls participating in the DZNE (German Center for Neurodegenerative Diseases) longitudinal study on cognition and dementia (DELCODE). Tau plasma levels were measured using ultra-sensitive, single-molecule array (Simoa) technology. We found no significant different tau plasma levels in SCD (3.4 pg/ml) compared with healthy controls (3.6 pg/ml) after controlling for age, gender, and education (p = 0.137). In addition, tau plasma levels did not correlate with Aβ42 (r = 0.073; p = 0.634), tau (r = −0.179; p = 0.240), and p-tau181 (r = −0.208; p = 0.171) cerebrospinal fluid (CSF) levels in a subgroup of 45 SCD patients with available CSF. In conclusion, plasma tau is not increased in SCD patients. In addition, the lack of correlation between tau in plasma and CSF in the examined cohort suggests that tau levels are affected by different factors in both biofluids.
| Type: | Article |
|---|---|
| Title: | Tau plasma levels in subjective cognitive decline: Results from the DELCODE study |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/s41598-017-08779-0 |
| Publisher version: | http://dx.doi.org/10.1038/s41598-017-08779-0 |
| Language: | English |
| Additional information: | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| Keywords: | Science & Technology, Multidisciplinary Sciences, Science & Technology - Other Topics, LINKED-IMMUNOSORBENT-ASSAY, EARLY ALZHEIMERS-DISEASE, CEREBROSPINAL-FLUID, MEMORY IMPAIRMENT, DEMENTIA, PROTEINS, RISK, MCI, CSF |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Div of Psychology and Lang Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Div of Psychology and Lang Sciences > Institute of Cognitive Neuroscience |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10025790 |
Archive Staff Only
 |
View Item |
